Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/17/2009CA2211459C A method for making heteromultimeric polypeptides
11/17/2009CA2206515C Identification of genes which allow a microorganism to adapt to a particular environment
11/17/2009CA2157577C Growth differentiation factor-8
11/12/2009WO2009137832A2 Autoantibodies in the detection and treatment of cancer
11/12/2009WO2009137632A2 Hiv immunogen and method of making and using same
11/12/2009WO2009137577A2 Leishmania vaccine using sand fly salivary immunogen
11/12/2009WO2009137378A2 Sequential administration of chemotherapeutic agents for treatment of cancer
11/12/2009WO2009137075A1 Anti-activin antibodies and uses for promoting bone growth
11/12/2009WO2009137044A2 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells
11/12/2009WO2009136941A1 Composition and methods of treatment of bacterial meningitis
11/12/2009WO2009136780A1 Anti-allergic vaccine for treating recurrent inflammation of the respiratory tract
11/12/2009WO2009136671A1 P53 regulatory protein and uses thereof
11/12/2009WO2009136373A1 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
11/12/2009WO2009136086A2 Method of screening for antitubercular compounds
11/12/2009WO2009136070A1 Novel antibodies used to treat cancer
11/12/2009WO2009136031A1 Use of an anti-cd151 antibody for early treatment of cancer
11/12/2009WO2009135614A2 Use of a virus regimen for the treatment of diseases
11/12/2009WO2009135295A1 Phage lambda display constructs
11/12/2009WO2009115508A3 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
11/12/2009WO2009114560A3 Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
11/12/2009WO2009111691A3 Combination therapy with c-met and egfr antagonists
11/12/2009WO2009111088A3 Antitumor immunization by liposomal delivery of vaccine to the spleen
11/12/2009WO2009105729A9 Immunogenic influenza composition
11/12/2009WO2009103035A3 Templated open flocs of anisotropic particles for enhanced pulmonary delivery
11/12/2009WO2009101604A3 Recombinant lumpy skin disease virus for preventing aids
11/12/2009WO2009099672A3 Breaking immunological tolerance with a genetically encoded unnatural amino acid
11/12/2009WO2009093143A3 Therapeutic vaccines
11/12/2009WO2009087577A3 Barb4 target which comprises tata-binding protein-associated factor 15, antibody designated barb4, barb4 related antibodies, and methods of making and using same
11/12/2009WO2009085200A3 Anti-amyloid antibodies and uses thereof
11/12/2009WO2009080715A3 Vaccines for malaria
11/12/2009WO2009002521A3 Compositions of specific binding agents to hepatocyte growth factor
11/12/2009WO2008131315A8 Identification and method for using the pre-ligand assembly domain of the il-17 receptor
11/12/2009WO2008020335A3 Immunogenic compositions for streptococcus agalactiae
11/12/2009US20090282496 Androgen Receptor Related Methods for Treating Bladder Cancer
11/12/2009US20090281285 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/12/2009US20090281170 Polynucleotide therapy
11/12/2009US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009US20090281043 Tumor antigen based on products of the tumor suppressor gene wt1
11/12/2009US20090280561 Fusion protein of hiv regulatory/accessory proteins
11/12/2009US20090280503 Method for detecting and treating skin disorders
11/12/2009US20090280210 Milk production method
11/12/2009US20090280183 Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration
11/12/2009US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009US20090280167 Enhancement of drug therapy by mirna
11/12/2009US20090280148 Casein nanoparticle
11/12/2009US20090280146 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
11/12/2009US20090280145 Adjuvant viral particle
11/12/2009US20090280144 Recombinant newcastle disease virus RNA expression systems and vaccines
11/12/2009US20090280143 Genetic adjuvants for immunotherapy
11/12/2009US20090280142 Methods of diagnosis and treatment of osteoporosis
11/12/2009US20090280141 Streptococcal Genes
11/12/2009US20090280140 assaying biological fluid sample from subject having symptoms of active tuberculosis for presence of early antibodies specific for a 27 kDa mycobacterial tuberculosis protein named MPT51
11/12/2009US20090280139 Novel Norovirus Particle for Use as an Antiviral or Vaccine
11/12/2009US20090280138 Peptide
11/12/2009US20090280137 Methods, Compositions, and Sequences of ZP-Binding Peptides for Immunocontraception of Dogs and Other Animals
11/12/2009US20090280136 Immunization of fish with plant-expressed recombinant proteins
11/12/2009US20090280135 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
11/12/2009US20090280134 Compositions and methods for inhibiting toxin a from clostridium difficile
11/12/2009US20090280133 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
11/12/2009US20090280132 Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease
11/12/2009US20090280131 IL-17 Antagonistic Antibodies
11/12/2009US20090280130 Method for the treatment of anthrax toxicity
11/12/2009US20090280129 High concentration antibody and protein formulations
11/12/2009US20090280128 Anti-ilt7 antibody
11/12/2009US20090280127 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-i
11/12/2009US20090280126 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans
11/12/2009US20090280125 Prion epitopes and methods of use thereof
11/12/2009US20090280124 Methods for the Diagnosis and Treatment of Preeclampsia
11/12/2009US20090280123 comprising a nucleic acid sequence encoding a KIF18A polypeptide being expressed in mesenchymal stem cells; kinesins capable of binding estrogen receptors
11/12/2009US20090280122 Use of a virus regimen for the treatment of diseases
11/12/2009US20090280121 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
11/12/2009US20090280120 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
11/12/2009US20090280119 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
11/12/2009US20090280118 antibody that binds the same epitope of alpha v beta 5 as bound by ALULA ; Pulmonary edema
11/12/2009US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009US20090280116 Humanized antibodies against tl1a
11/12/2009US20090280115 Dihydropteridinones in the Treatment of Respiratory Diseases
11/12/2009US20090280114 Prevention of brain inflammation as a result of induced autoimmune response
11/12/2009US20090280113 Target for regulating multiple sclerosis
11/12/2009US20090280112 Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells
11/12/2009US20090280111 Isolation of the Mitotic Spindle Matrix and its Methods of Use
11/12/2009US20090280110 Cell Model for Alzheimer's Disease Pathology
11/12/2009US20090280109 ILT3 and ILT4-related compositions and methods
11/12/2009US20090280108 Serum amyloid a protein in inflammation and obesity
11/12/2009US20090280082 Methods for treating autoimmune disorders
11/12/2009US20090280065 Uses and Compositions for Treatment of Psoriasis
11/12/2009US20090280056 Antibodies and immunoconjugates and uses therefor
11/12/2009CA2761105A1 Phage lambda display constructs
11/12/2009CA2725548A1 Autoantibodies in the detection and treatment of cancer
11/12/2009CA2723722A1 Igf-ii/gf-iie binding proteins
11/12/2009CA2723219A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
11/12/2009CA2722992A1 Sequential administration of chemotherapeutic agents for treatment of cancer
11/12/2009CA2721713A1 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
11/12/2009CA2720904A1 Novel antibodies used to treat cancer
11/12/2009CA2717119A1 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
11/11/2009EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009EP2116596A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
11/11/2009EP2116556A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
11/11/2009EP2116265A2 Reduced-viscosity concentrated protein formulations
11/11/2009EP2116262A2 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
1 ... 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 ... 1823